Table 3 Champalimaud Clinical Centre (DaT-SPECT) cohort demographics

From: Relative sparing of dopaminergic terminals in the caudate nucleus is a feature of rest tremor in Parkinson’s disease

 

Positive

Negative

P-value

n

34 (39.5%)

52 (60.5%)

 

Age (yr)

65.1 (10.2)

65.1 (14.9)

0.988

Female, n (%)

21 (61.8)

31 (60.8)

1.000

DA treatment, n (%)

17 (50.0)

8 (16.0)

0.002*

Tremor treatment, n (%)

1 (2.9)

13 (26.0)

0.013*

LEDD (mg/day)

183.8 (295.2)

51.6 (138.7)

0.021*

Symptom onset (months)

43.3 (70.1)

41.2 (51.1)

0.884

MDS-UPDRS III Total

21.4 (14.7)

14.2 (12.2)

0.021*

Rigidity

2.9 (2.7)

1.1 (1.6)

0.001*

Bradykinesia

11.3 (8.5)

7.4 (7.2)

0.031*

Rest tremor

1.1 (1.7)

0.7 (1.2)

0.270

Tremor

3.2 (3.6)

3.2 (4.0)

0.976

  1. DA dopamine, LEDD Levodopa Equivalent Daily Dose, MDS-UPDRS Movement Disorder Society-sponsored Unified Parkinson’s Disease Rating Scale. *P < 0.05.
Back to article page